Qiming Corporate GP VI, Ltd. sold 2,084 shares of Alamar Biosciences, Inc. at $30.63 for −$63.8k on Nov 11, 2026

Sell
Form 4 code S. Open-market or private sale of a non-derivative or derivative security.
10% owner
10%
Filed Nov 13, 2026

Facts from the filing

Form 4 · Non-derivative, table I
Disclosed value
−$63,832.92Shares × reported price
Shares traded
2,084Common Stock
Price per share
$30.63Reported price. Read footnotes for ranges.
% of reported position traded
0.04%This security and ownership context
Holdings after
5,842,775Indirect · See footnote
Trade date
Nov 11, 2026Sell
Filed
Nov 13, 2026, 9:02 PM ET3-day reporting delay
Accession
0001231919-26-001575Code S · Transaction 401513
How reported position traded is calculated

Shares sold ÷ (holdings after + shares sold). Estimated position before: 5,844,859 shares.

Row-level estimate for this security and ownership context, not the insider’s complete portfolio. Joint ownership, other transactions in the filing, amendments and footnotes can affect interpretation.

Other trades in this filing

Trade dateActivitySharesPriceValueDetails
Nov 11, 2026Sell1,694$29.34−$49,701.96Trade 401510
Nov 11, 2026Sell56$30.63−$1,715.28Trade 401511
Nov 11, 2026Sell62,944$29.34−$1,846,776.96Trade 401512
Nov 11, 2026Sell14,687$29.34−$430,916.58Trade 401514
Nov 11, 2026Sell486$30.63−$14,886.18Trade 401515
Nov 11, 2026Sell17,584$29.34−$515,914.56Trade 401516
Nov 11, 2026Sell582$30.63−$17,826.66Trade 401517
8 transaction rows in this filing. Joint filers share the same rows.

ALMR price since this filing

Daily closing prices, with the filing date and available return windows. Return methodology
ALMR · Daily closing priceDaily price data is pending. The chart appears when valid daily closes are available.
Filing dateReturn windows appear as prices become available.

Return windows are pending. The first 7-day window is eligible on Nov 21, 2026. Values appear when the daily price refresh supplies a valid close for that window. Weekends, market holidays and missing prices can delay updates.

Pre-filing1mo ago −21%1w ago −11%1d ago +2.2%
Returns since7d30d90d180d1y

Footnotes in full

F1: The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $29.40 to $30.22, inclusive. The reporting person undertakes to provide to Alamar Biosciences, Inc., any security holder of Alamar Biosciences, Inc., or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in the footnotes (1) and (3) to this Form 4. F2: These shares are held of record by Qiming Managing Directors Fund VI, L.P. ("Qiming Managing Directors"). Qiming Corporate GP VI, Ltd. ("Qiming Corporate") serves as the general partner of Qiming Managing Directors and may be deemed to have voting and dispositive power over the shares held by Qiming Managing Directors. Qiming Corporate disclaims beneficial ownership of such shares, except to the extent of its proportionate pecuniary interest therein. F3: The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $30.38 to $30.94, inclusive. F4: These shares are held of record by Qiming Venture Partners VI, L.P., ("Qiming Venture Partners VI"). Qiming Corporate, through one intermediary, serves as the indirect general partner of Qiming Venture Partners VI and may be deemed to have voting and dispositive power over the shares held by Qiming Venture Partners VI. Qiming Corporate disclaims beneficial ownership of such shares, except to the extent of its proportionate pecuniary interest therein. F5: These shares are held of record by Qiming Venture Partners VIII Investments, LLC ("QVP VIII LLC"). Qiming GP VIII, LLC, through two parallel intermediaries, serves as the indirect general partner of QVP VIII LLC and may be deemed to have voting and dispositive power over the shares held by QVP VIII LLC. Qiming GP VIII, LLC disclaims beneficial ownership of such shares, except to the extent of its proportionate pecuniary interest therein. F6: These shares are held of record by Qiming Venture Partners VIII-HC, L.P. ("QVP VIII-HC"). Qiming GP VIII-HC, LLC serves as the general partner of QVP VIII-HC and may be deemed to have voting and dispositive power over the shares held by QVP VIII-HC. Qiming GP VIII-HC, LLC disclaims beneficial ownership of such shares, except to the extent of its proportionate pecuniary interest therein.